Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
Cho, HJ; Kim, SS; Ahn, SJ; Park, JH; Kim, DJ; Kim, YB; Cho, SW; Cheong, JY
Clinical and molecular hepatology, 20(4):347-354, 2014
Clinical and molecular hepatology
Background/Aims: Transferrin and alpha-1 antitrypsin are reportedly associated with liver fibrosis. We evaluated the usefulness of serum transferrin and alpha-1 antitrypsin as new liver fibrosis markers in patients with chronic hepatitis B.
Methods: The study included 293 patients with chronic hepatitis B who underwent a liver biopsy between October 2005 and June 2009, and who had no history of hepatocellular carcinoma. Serum markers and liver fibrosis stages were compared.
Results: Univariate analysis revealed that age (P<0.001), serum platelet count (p<0.001), and serum alkaline phosphatase level (p=0.003) differed significantly between the patients with and without liver cirrhosis. Serum transferrin levels were significantly lower in advanced fibrosis than in mild fibrosis in both univariate analysis (p=0.002) and multivariate analysis (p=0.009). In addition, the serum transferrin level was significantly lower in cirrhotic patients than in noncirrhotic patients (p=0.020). However, the serum level of alpha-1 antitrypsin was not significantly associated with liver cirrhosis in patients with chronic hepatitis B.
Conclusions: transferrin could be promising serum marker for predicting advanced liver fibrosis in patients with chronic hepatitis B.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :3,092,869
Total Download :1,262,069
Today View :391
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.